Tuberculosis drug shows promise against latent bacteria
Saturday, September 13, 2008 - 11:56
in Health & Medicine
A new study has shown that an investigational drug (R207910, currently in clinical trials against multi-drug resistant tuberculosis strains) is quite effective at killing latent bacteria. This revelation suggests that R207910 may lead to improved and shortened treatments for this globally prevalent disease.